| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
protein C receptor | 0.560 | 0.692 | 5.6E-03 |
|
disease | 0.120 | None | 0.667 | 1 | 1 | 2005 | 2011 | ||||||||
|
nuclear receptor subfamily 1 group H member 3 | 0.566 | 0.692 | 0.90 |
|
disease | 0.150 | None | 0.833 | 1 | 1 | 2006 | 2014 | ||||||||
|
collagen type IV alpha 2 chain | 0.563 | 0.654 | 3.6E-15 |
|
disease | 0.150 | None | 0.857 | 2 | 1 | 2011 | 2018 | ||||||||
|
arachidonate 5-lipoxygenase | 0.447 | 0.885 | 1.2E-06 |
|
disease | 0.190 | None | 0.900 | 1 | 1 | 2005 | 2019 | ||||||||
|
transcription factor 21 | 0.537 | 0.692 | 0.83 |
|
disease | 0.190 | None | 0.909 | 1 | 1 | 2011 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.500 | None | 0.912 | 1 | 1 | 1991 | 2019 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.200 | None | 0.938 | 1 | 1 | 1980 | 2019 | |||||||||
|
lipase C, hepatic type | 0.585 | 0.654 | 3.3E-07 |
|
disease | 0.200 | None | 0.941 | 1 | 1 | 1997 | 2016 | ||||||||
|
cholesteryl ester transfer protein | 0.512 | 0.731 | 1.2E-23 |
|
disease | 0.200 | None | 0.947 | 1 | 3 | 1990 | 2020 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
disease | 0.200 | None | 0.960 | 1 | 5 | 2000 | 2019 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
disease | 0.500 | None | 0.960 | 1 | 1 | 1986 | 2019 | ||||||||
|
low density lipoprotein receptor | 0.449 | 0.885 | 9.8E-24 |
|
disease | 0.500 | None | 0.967 | 2 | 2 | 1986 | 2020 | ||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
disease | 0.500 | None | 0.968 | 2 | 2 | 1988 | 2019 | ||||||||
|
proprotein convertase subtilisin/kexin type 9 | 0.482 | 0.808 | 2.7E-17 |
|
disease | 0.200 | None | 0.986 | 1 | 1 | 2006 | 2020 | ||||||||
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
disease | 0.400 | None | 0.987 | 1 | 1 | 1993 | 2020 | ||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.200 | None | 1.000 | 12 | 23 | 2007 | 2020 | |||||||||
|
phosphatase and actin regulator 1 | 0.663 | 0.423 | 0.64 |
|
disease | 0.200 | None | 1.000 | 6 | 3 | 2011 | 2019 | ||||||||
|
MIA SH3 domain ER export factor 3 | 0.716 | 0.423 | 3.7E-02 |
|
disease | 0.150 | None | 1.000 | 5 | 3 | 2007 | 2017 | ||||||||
|
muscle RAS oncogene homolog | 0.590 | 0.731 | 0.92 |
|
disease | 0.400 | None | 1.000 | 3 | 2 | 2009 | 2017 | ||||||||
|
HECT domain E3 ubiquitin protein ligase 4 | 0.700 | 0.462 | 1.00 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2012 | 2013 | ||||||||
|
zinc finger C3HC-type containing 1 | 0.760 | 0.308 | 2.6E-04 |
|
disease | 0.440 | None | 1.000 | 3 | 1 | 2011 | 2019 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.450 | 0.885 | 1.00 |
|
disease | 0.130 | None | 1.000 | 3 | 3 | 2010 | 2017 | ||||||||
|
phospholipid phosphatase 3 | 0.722 | 0.192 | 0.92 |
|
disease | 0.180 | None | 1.000 | 3 | 3 | 2011 | 2019 | ||||||||
|
lipase A, lysosomal acid type | 0.564 | 0.654 | 5.5E-07 |
|
disease | 0.160 | None | 1.000 | 3 | 3 | 2003 | 2019 | ||||||||
|
TCF21 antisense RNA inducing promoter demethylation | 0.821 | 0.308 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2011 | 2012 |